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favirenz and positive urine test for cannabis - debunkng the
yth
.C. Koh1,∗, Z.W. Daniel Eh1, W.-Y. Lee1, T.Murgiah2, N.J. Ismail1,
.S. Tee1, A. Othman2
International Medical University, Seremban, Negeri Sembilan,
alaysia
Hospital Tuanku Ja’afar, Seremban, Negeri Sembilan, Malaysia
Background: Urine tests for cannabis were positive in some
f patients who were detained by law-enforcers. These patients,
n their defense, claimed that the test results were false-positives
aused by Efavirenz which they were taking for the treatment of
IV infection. While in detention, some patients were deprived
f their Highly Active Antiretroviral Therapy (HAART). This issue
as become controversial for the patients, the law-enforcement
gencies and the doctors treating these patients.
This study was done to evaluate if urine collected from patients
aking Efavirenz would produce positive urine test results for
annabis using the same urinalysismethod used byMalaysian law-
nforcement agencies.
Methods: Urine samples were collected from HIV-infected
atients taking Efavirenz as part of HAART and tested for cannabi-
oids using the AxSYM Cannabinoids Assay® (Abbott, USA) which
as a sensitivity of 13 ng/mL. Epidemiological data were collected
rom patient case notes and from face-to-face interviews. Descrip-
ive analysis was done using SPSS® v.17 for Windows.
Results: 44 patients on Efavirenz were recruited. The mean age
as 44.8 years (23-73 years), 12 (27.3%) females. Mean-years on
favirenz, 3.8 years (1-14 years). Mean CD4 cell count on HAART
nitiation, 123.7 cells/uL (4-377). All were compliant in taking
favirenz in the preceding 7days before recruitment and38 (86.4%)
ook Efavirenz within 30minutes of scheduled time while the rest
ook Efavirenz within 60minutes of scheduled time. 4 patients had
istory of detention by law-enforcers; 2 were taking Efavirenz at
he time, of which 1 tested positive for urine cannabis and he was
eprived of HAART during detention. Urine test for cannabis was
egative for all 44 patients.
Conclusion:Urine tests for cannabis (using theAxSYMCannabi-
oids Assay) were negative for all patients taking Efavirenz as part
f HAART in this study. These patientswere adherent toHAART.We
onclude that Efavirenz is unlikely to be the cause of positive urine
est for cannabis using the AxySYM Cannabinoids Assay which is
sed by law enforcement agencies in Malaysia.
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HIV-1 subtypes in Jayapura City, Papua Province Indonesia
A. Oktavian1, T.N. Kridaningsih1,∗, H.A. Wibowo2, M. Widiyanti1,
I. Wieke1, E. Fitriana1
1 National Institute Of Research and Development for Biomedicine
Papua, Jayapura, Indonesia
2 National Institute of Health Research and Development, Jakarta,
Indonesia
Background: Papua Province has the highest HIV prevalence
in Indonesia. In September 2011, there were 10.522 HIV/AIDS
cases cumulatively with 18% (1.914) cases from Jayapura City, with
95,08% were transmitted through heterosexual intercourse. There
is no data about HIV-1 subtypes in Jayapura City
A cross sectional serological survey was intended to identify the
subtype of HIV-1 in Jayapura City Papua Province, Indonesia
Methods: The study was carried out in two Voluntary Coun-
seling Testing Clinics in Jayapura Hospital and Abepura Hospital
among 60 subjects with HIV/AIDS on May to November 2011. We
used questioner for demographic data, history of illness variables
and serological test with PCR and DNA sequencing to indentify the
subtype of HIV-1, in two laboratory: Biomolocular Laboratory of
National Institute for Biomedicine Papua for PCR procedure and
Biomolecular laboratory of Centre for Biomedicine andBasicHealth
Technology Jakarta.
Results: We found 39 (65%) subjects with HIV subtype B, 20
(33%) subtype AE and 1 (3%), un subtype. 97,4% subtype B and 95,2%
non subtype B were heterosexual
Conclusion: There is no relation between HIV subtype with risk
factor of the infection in this study.
http://dx.doi.org/10.1016/j.ijid.2012.05.747
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Eight years of prevention of parent to child transmission ofHIV-
AIDS programme (PPTCT) in a tertiary care hospital in India
M. Kulkarni ∗, G.S. Vijay Kumar, A. Bhandiwad
JSS Medical College and Hospital, Mysore, India
Background: The PPTCT programmewas started in the country
in the year 2002 after a feasibility study in the 5 high prevalence
states and aimed to prevent perinatal transmission of HIV. It entails
counseling and testing of pregnant women in the integrated cen-
ters for counseling and testing (ICTC)s and single dose nevirapine
(SDNVP) for mother and baby.This study was carried out according to National AIDS Control
Organisation (NACO) protocols, with enrollment, counseling, test-
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ng, and interventions to prevent perinatal transmission of HIV, at
SS Hospital, Mysore.
Methods: All women attending antenatal clinics of the hos-
ital from October 2002 to December 2010 were counseled and
ubjected to HIV testing after an informed consent. Those found
ositive, were conﬁrmed to be seropositive, by two more rapid
ests. Such women were given SDNVP (200mg) at the onset of
abour.Ceasarian delivery was carried out with universal precau-
ions. Neonate was administered SDNVP (2mg/kg body weight)
t birth. Exclusive breast feeding was advised, baby followed up.
ested at 18 months of age by rapid tests for HIV.
Results: Out of 21003 women tested, 71 were conﬁrmed posi-
ive. 46 (65%) patients delivered in our hospital. 30 patients were
ollowed up for up to 18 months. None of these babies were
eropositive at 18 months.
Conclusion: The intervention in PPTCT to signiﬁcantly reduce
erinatal transmission of HIV can be successful if guidelines are
ollowed strictly and if the services are integrated with Maternal
nd Child Health services of the hospitals.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.748
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oles of mixing of drug-use network and sexual network on
eterosexual transmission of HIV among young drug users: an
gocentric network study in Yunnan, China
. Liu1,∗, J. Li 2, J. Li 1
Virginia Commonwealth University, Richmond, VA, USA
Yunnan Institute for Drug Abuse, Kunming, China
Background: The heterosexually transmitted HIV infection rate
s rapidly increasing among young drug users in China. HIV trans-
ission may be inﬂuenced by mixing of drug-use network and
exual network characteristics.
Methods: A community-based survey was conducted in Yun-
an, China, in which respondent-driving sampling (RDS) was used
o sample heroin users who were 18-35 years old. Using an ego-
entric social network questionnaire, we deﬁned two types of
etworks: drug use network and sexual network. Respondents
ere deﬁned as having mixing networks if they reported having
ad both a sexual network and a drug-use network.
Results: Among 426 respondents, 242 reported having had
ixing of both sexual network and drug-use network. The RDS-
djusted proportion of respondents having mixing networks was
6%. Among those who had mixing networks, 26% reported hav-
ng had both injection drug using (IDU) peers and non-injection
rug using (NIDU) peers, and 32% having had both regular and
on-regular sexual partners in their networks. Compared to those
ithout mixing networks, respondents with mixing were more
ikely to engage in risks forHIV infection. Speciﬁcally,more respon-
ents with mixing networks than those without reported having
ad (1) 2-3 sexual partners (31% vs. 20%), (2) both regular and
on-regular sexual partners (26% vs. 21%), (3) concurrent sexual
artnerships (52% vs. 40%), (4) IDU network peers (79% vs. 30%),
nd (6) NIDU peers in their network (48% vs. 33%). Consistent con-
om use with regular or non-regular partners was low in the two
roups, between 18% and 46%. The risk of parenteral transmissionfectious Diseases 16S (2012) e158–e316
of HIV was relatively low. Measured over life time, only about 2%
of drug users with or without mixing networks shared needles for
half or more episodes of injecting. Over the last 30 days, only 8% of
drug users with mixing networks and 4% of those without had ever
sheared them with others.
Conclusion: The ﬁndings of this study document that het-
erosexual HIV transmission can be driven by mixing patterns of
drug-use network and sexual network and the generalization of
the HIV epidemic from high-risk groups to the general population.
Effective intervention programs should take the characteristics of
mixing into consideration.
http://dx.doi.org/10.1016/j.ijid.2012.05.749
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Factors inﬂuencing the initiation of antiretroviral therapy in
HIV infected patients attending the Bamenda and the Bertoua
regional treatment centers in Cameroon
F.-X.Mbopi-Keou1,∗, E. Voundi Voundi2, I. Emah3, F. Angwafo III 1,
W. Muna1
1 Ministry of Health & University of Yaounde I, Yaounde, Cameroon
2 Ministry of Health, Bertoua, Cameroon
3 Ministry of Health, Yaounde, Cameroon
Background: In sub-Saharan Africa, access to antiretroviral
drugs (ARVs) remains low due to various obstacles. Encouraging
progress in the availability of these drugs in Cameroon has been
noted leading to an increase number of treatment centers and an
increase number of patients under ARVs. The present study aimed
at determining the factors inﬂuencing the initiation of ARV therapy
in HIV infected patients attending the Bamenda and the Bertoua
regional treatment centers in Cameroon (RTC).
Methods: A cross sectional study involving 460 ﬁles of HIV
infected adult patients attending the Bamenda and the Bertoua RTC
was carried out from January to April 2011. Socio-demographic,
biological and clinical characteristics including the antiretroviral
treatment were compared between these RTC. Data were analysed
using the Chi-Squared and the Ficher, and statistical signiﬁcance
was set at p <0.05.
Results: Out of the 460 ﬁles, 53.9% were from Bamenda and
46.1% from Bertoua RTC. The median age of patients was 36 years
in Bamenda and 35 years in Bertoua. There were more female
patients in both the Bamenda (69, 0%) and the Bertoua (61, 8%)
RTC (p=0.11). The majority of patients in Bertoua discovered their
HIV status through voluntary testing as compared to those in
Bamenda (41 vs 22; p=0.008). HIV type 1 and 2 viruses were
more frequent in Bamenda than in Bertoua (15 vs 3; p=0.011).
The median CD4 count was 133 cells/mm3 in Bamenda and 175
cell/mm3 in Bertoua (p=0.008). Standard ﬁrst line ARV drugs were
the most used protocols [Bamenda (93.1%) and Bertoua (98.1)].
Zidovudine, Nevirapine and Lopinavir were more frequently used
in Bamenda (p=0.000), while Tenofovir and Effavirenz were more
used in Bertoua (p=0.017).Conclusion: This study highlights the fact that socio-
demographic, biological and clinical management of patients differ
from one RTC to the other in Cameroon, even when both have a
high HIV prevalence. We therefore recommend the standardiza-
